R&D News | pharmaphorum

News

Roche's Gazyva breaks new ground in lupus

Already approved for kidney damage in lupus, Roche's Gazyva could be heading for broader use in the potentially life-threatening autoimmune disorder.

News

Free Wegovy trialled in deprived areas of Scotland

Thousands of people from Scotland's most deprived areas will get free weight-loss jabs in a real-world study to gauge if they can save the NHS money.

News

Pfizer sues to block Novo Nordisk's Metsera takeover bid

Pfizer has filed a lawsuit to block a rival, higher bid for obesity therapy developer Metsera from Novo Nordisk, claiming it is anti-competitive.

News

AZ trumpets results for new injectable C5 drug for gMG

AstraZeneca's gefurulimab could give gMG patients the first treatment option that they can self-administer at home once a week.

News

MSD still seeking deals 'with urgency' after Verona takeover

MSD has only just completed its $10 billion takeover of Verona Pharma, but is still on the hunt for more bolt-on acquisitions.

News

Electra banks $183m for sHLH drug, and other biofinancings

Our round-up of recent biotech financings includes a big round for Electra, with Hemab, Zag Bio, Elevara, Expedition, and Curve also adding new funds.

Roche's Gazyva breaks new ground in lupus

Free Wegovy trialled in deprived areas of Scotland

Pfizer sues to block Novo Nordisk's Metsera takeover bid

AZ trumpets results for new injectable C5 drug for gMG

MSD still seeking deals 'with urgency' after Verona takeover

Electra banks $183m for sHLH drug, and other biofinancings

AI, start-ups, and the future of human health: AION Labs’ Ma...

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks